PainReform licenses Encore's post-surgical pain product

The pain management company [C#200800469:PainReform]has entered into its first major licence agreement by signing a deal with[C#200800470:Encore Therapeutics], which gives the Israeli firm exclusive North American rights to Encore's post-surgical pain product, ETI-211, as well as the option to expand the agreement to other countries including Japan and the EU.